Advanced search
Publication Cover
Cancer Biology & Therapy Volume 19, 2018 - Issue 10
Submit an article Journal homepage
1,128
Views
0
CrossRef citations to date
0
Altmetric
Journal Club

Molecular drivers of metastatic castrate-resistant prostate cancer: New roads to resistance

Phoebe A. HuangGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAView further author information
,
Douglas K. PriceGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAView further author information
&
William D. FiggGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USACorrespondence[email protected]
View further author information
Pages 869-870 | Received 30 Jan 2018, Accepted 03 Mar 2018, Published online: 14 May 2018

References

  • Chen WY, Tsai YC, Yeh HL, Suau F, Jiang KC, Shao AN, Huang J, Liu YN. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer. Sci Signal. 2017;10. doi:10.1126/scisignal.aam6826.
  • Coutinho I, Day TK, Tilley WD, Selth LA. Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence. Endocr Relat Cancer. 2016;23:T179–T97. doi:10.1530/ERC-16-0422. PMID:27799360.
  • Zhu ML, Kyprianou N. Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. FASEB J. 2010;24:769–77. doi:10.1096/fj.09-136994. PMID:19901020.
  • Boudadi K, Antonarakis ES. Resistance to novel antiandrogen therapies in metastatic castration-resistant prostate cancer. Clin Med Insights Oncol. 2016;10:1–9. PMID:27013902
  • Edwards J, Krishna NS, Grigor KM, Bartlett JM. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer. 2003;89:552–6. doi:10.1038/sj.bjc.6601127. PMID:12888829.
  • Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL. Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2004;10:33–9. doi:10.1038/nm972. PMID:14702632.
  • Montanari M, Rossetti S, Cavaliere C, D'Aniello C, Malzone MG, Vanacore D, Di Franco R, La Mantia E, Iovane G, Piscitelli R, et al. Epithelial-mesenchymal transition in prostate cancer: an overview. Oncotarget. 2017;8:35376–89. doi:10.18632/oncotarget.15686. PMID:28430640.
  • Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res. 2007;13:7003–11. doi:10.1158/1078-0432.CCR-07-1263. PMID:18056176.
  • Sun Y, Wang BE, Leong KG, Yue P, Li L, Jhunjhunwala S, Chen D, Seo K, Modrusan Z, Gao WQ, et al. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res. 2012;72:527–36. doi:10.1158/0008-5472.CAN-11-3004. PMID:22108827.
  • Pu H, Begemann DE, Kyprianou N. Aberrant TGF-beta signaling drives castration-resistant prostate cancer in a male mouse model of prostate tumorigenesis. Endocrinology. 2017;158:1612–22. doi:10.1210/en.2017-00086. PMID:28324007.
  • Steffan JJ, Koul S, Meacham RB, Koul HK. The transcription factor SPDEF suppresses prostate tumor metastasis. J Biol Chem. 2012;287:29968–78. doi:10.1074/jbc.M112.379396. PMID:22761428.
  • Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, et al. Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nat Med. 2010;16:1414–20. doi:10.1038/nm.2236. PMID:21057494.
  • Abrahamsson PA. Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature. Eur Urol. 2010;57:49–59. doi:10.1016/j.eururo.2009.07.049. PMID:19683858.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.